Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Preliminary findings suggest that this higher dosage may enhance the drug's ability to control blood glucose, potentially offering more significant outcomes for individuals with diabetes. Further research is underway to fully understand